Medicare Enrolled

Dr. Sara Seghezzo, M.D.

Allergy & Immunology · Seattle, WA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
9725 3RD AVE NE STE 500, Seattle, WA 98115
2065271200
In practice since 2014 (12 years)
NPI: 1962822874 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Seghezzo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Seghezzo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Seghezzo

Dr. Sara Seghezzo is an allergy & immunology specialist in Seattle, WA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Seghezzo performed 4,889 Medicare services across 283 unique beneficiaries.

Between the years covered by Open Payments, Dr. Seghezzo received a total of $2,571 from 18 pharmaceutical and/or device companies across 89 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy & immunology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Seghezzo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 37% volume in WA $2,571 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,889
Medicare services
Top 37% in WA for allergy & immunology
283
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~407 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Omalizumab injection (Xolair) for asthma/allergy 3,645 $30 $52
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
415 $3 $15
Allergy immunotherapy preparation
A professional service involving the preparation and administration of one or more antigens.
270 $14 $25
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
167 $12 $48
Allergen injection administration
Professional service for the administration of a single allergen injection.
144 $8 $20
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
109 $9 $24
Health risk assessment administration and interpretation
This procedure involves administering a health risk assessment to a patient and interpreting the results.
37 $2 $17
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
23 $68 $147
Airflow rate measurement test
A test that measures the rate of airflow. This procedure assesses how quickly air moves.
22 $30 $79
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
22 $15 $37
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
20 $86 $217
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
15 $126 $330
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,571
Total received (2019-2024)
Avg $429/year across 6 years
Top 40% in WA for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
18
Companies
89
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,482 (96.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$65 (2.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$24 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,120
2023
$539
2022
$296
2021
$218
2020
$151
2019
$248

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$520
GENZYME CORPORATION
$174
Amgen Inc.
$78
Regeneron Healthcare Solutions, Inc.
$69
GlaxoSmithKline, LLC.
$61
Takeda Pharmaceuticals U.S.A., Inc.
$44
BioCryst US Sales Co., LLC
$39
PFIZER INC.
$36
Blueprint Medicines Corporation
$36
ADMA BioManufacturing LLC
$24
Genentech USA, Inc.
$22
kaleo, Inc.
$18
Top 3 companies account for 69.0% of 2024 payments
All-time payments by company (2019-2024) ›
AstraZeneca Pharmaceuticals LP
$1,358
PFIZER INC.
$285
GENZYME CORPORATION
$208
Amgen Inc.
$97
Takeda Pharmaceuticals U.S.A., Inc.
$94
GlaxoSmithKline, LLC.
$80
Regeneron Healthcare Solutions, Inc.
$69
SANOFI-AVENTIS U.S. LLC
$65
NOVARTIS PHARMACEUTICALS CORPORATION
$46
ALK-Abello, Inc
$45
BioCryst US Sales Co., LLC
$39
Blueprint Medicines Corporation
$36
Shire North American Group Inc
$35
Novartis Pharmaceuticals Corporation
$33
ADMA BioManufacturing LLC
$24
Genentech USA, Inc.
$22
Aimmune Therapeutics, Inc.
$18
kaleo, Inc.
$18
Top 3 companies account for 72.0% of all-time payments
Associated products mentioned in payments ›
ACTIMMUNE · AIRSUPRA · AREXVY · AUVI-Q · AYVAKIT · BREZTRI · BRILINTA · CINRYZE · CUVITRU · DUPIXENT · EUCRISA · FASENRA · Grastek · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORLADEYO · PALFORZIA · SYMBICORT · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · XOLAIR · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an allergy & immunology specialist in Seattle?
Compare allergy & immunologists in the Seattle area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists within 10 mi
43
Per 100K population
1.9
County median income
$122,148
Nearest hospital
SEATTLE CHILDREN'S HOSPITAL
1.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Seghezzo is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Seghezzo experienced with omalizumab injection (xolair) for asthma/allergy?
Based on Medicare claims data, Dr. Seghezzo performed 3,645 omalizumab injection (xolair) for asthma/allergy services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Seghezzo receive payments from pharmaceutical companies?
Yes. Dr. Seghezzo received a total of $2,571 from 18 companies across 89 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Seghezzo's costs compare to other allergy & immunologists in Seattle?
Dr. Seghezzo's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Seghezzo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →